Global Biosimulation Market- By Component (Software and Services), By Application (Drug Development, Drug Discovery, and Other Applications), By Delivery Mode (Ownership Models and Subscription Models), By End-User (Contract Research Organizations (CROs), Regulatory Authorities, Biotech Companies, Pharma Companies, and Other End Users), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032
Report Overview In 2022, the Global Biosimulation Market was valued at USD 2.9 Billion and expected to grow USD 10.1 Billion in 2032. Between 2023 and 2032, this market is estimated ...
